Tudor, Iulia C.
Kaiser Permanente · The University of Texas MD Anderson Cancer Center · University of California, Los Angeles · University of California, San Francisco · Pfizer (United States) · The US Oncology Network · UCSF Helen Diller Family Comprehensive Cancer Center
3 papers on CoChatORCID 0000-0002-4229-2940
Most cited papers
- Verified
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
Litton, J. K., Rugo, H. S., Ettl, J., Hurvitz, S. A., Gonçalves, A., Lee, K.-H., Fehrenbacher, L., Yerushalmi, R., Mina, L. A., Martin, M., et al. (2018) · New England Journal of Medicine
PARP inhibition in cancer therapyBRCA gene mutations in cancer
Cited by 2,175
- Verified
Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease
Salloway, S., Sperling, R., Fox, N. C., Blennow, K., Klunk, W., Raskind, M., Sabbagh, M., Honig, L. S., Porsteinsson, A. P., Ferris, S., et al. (2014) · New England Journal of Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 1,960
- Verified
Amyloid-β 11 C-PiB-PET imaging results from 2 randomized bapineuzumab phase 3 AD trials
Liu, E., Schmidt, M. E., Margolin, R., Sperling, R., Koeppe, R., Mason, N. S., Klunk, W. E., Mathis, C. A., Salloway, S., Fox, N. C., et al. (2015) · Neurology
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 151
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free